Robert Dudczak
Overview
Explore the profile of Robert Dudczak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
1010
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anner P, Mayerhofer M, Wadsak W, Geleff S, Dudczak R, Haug A, et al.
Oncol Lett
. 2018 Feb;
15(3):3951-3956.
PMID: 29467905
The current study aimed to determine the optimum diagnostic imaging technique out of magnetic resonance imaging (MRI), F-fludeoxyglucose positron emission tomography/computed tomography ([F]FDG-PET/CT, otherwise known as PET/CT) and [F]FDG-PET/MRI (otherwise...
2.
El-Rabadi K, Weber M, Mayerhofer M, Nakuz T, Scherer T, Mitterhauser M, et al.
Anticancer Res
. 2016 Jul;
36(8):4187-93.
PMID: 27466530
Aim: To evaluate (18)F-fluorodihydroxyphenylalanine-positron emission tomography/ contrast-enhanced computed tomography ((18)F-DOPA PET/CT) for the detection of paragangliomas (PARA) without any patient selection, such as genetic predisposition for the development of these...
3.
Sesti A, Mayerhoefer M, Weber M, Anner P, Wadsak W, Dudczak R, et al.
Anticancer Res
. 2014 Nov;
34(11):6647-54.
PMID: 25368270
Aim: The American thyroid association (ATA) recommends that additional imaging procedures supplement cervical ultrasonography (US) in any patient with a basal calcitonin value above 150 pg/ml in the follow-up of...
4.
Magnaldi S, Mayerhoefer M, Khameneh A, Schuetz M, Javor D, Mitterhauser M, et al.
Anticancer Res
. 2014 Feb;
34(2):791-5.
PMID: 24511014
Aim: To describe the (18)F-fluorodihydro-xyphenylalanine ((18)F-DOPA), positron emission tomography (PET) and magnetic resonance imaging (MRI) appearance of pheochromocytomas, with a focus on the presence or absence of typical MRI features....
5.
Ungersboeck J, Philippe C, Haeusler D, Mitterhauser M, Lanzenberger R, Dudczak R, et al.
Appl Radiat Isot
. 2012 Sep;
70(11):2615-20.
PMID: 22940416
The intention for the present study was to implement a microfluidic set-up for N-(11)C-methylations in a flow-through microreactor device with [(11)C]DASB as model-compound and [(11)C]CH(3)I and [(11)C]CH(3)OTf, respectively, as (11)C-methylation...
6.
Ungersboeck J, Richter S, Collier L, Mitterhauser M, Karanikas G, Lanzenberger R, et al.
Nucl Med Biol
. 2012 May;
39(7):1087-92.
PMID: 22633218
Introduction: Our aim was the optimization of radiochemical parameters for the microfluidic preparation of [(18)F]altanserin. The four main parameters evaluated were (1) precursor concentration, (2) reaction temperature, (3) bolus flow...
7.
Traub-Weidinger T, Graf S, Beheshti M, Ofluoglu S, Zettinig G, Khorsand A, et al.
Thyroid
. 2012 Jan;
22(3):245-51.
PMID: 22233129
Background: The association of subclinical hypothyroidism (SCH) with increased risk for cardiovascular disease is still controversial. This study aimed to examine coronary vascular reactivity by positron emission tomography (PET) in...
8.
Ungersboeck J, Philippe C, Mien L, Haeusler D, Shanab K, Lanzenberger R, et al.
Nucl Med Biol
. 2011 Apr;
38(3):427-34.
PMID: 21492791
Introduction: Recently, first applications of microfluidic principles for radiosyntheses of positron emission tomography compounds were presented, but direct comparisons with conventional methods were still missing. Therefore, our aims were (1)...
9.
Knausl B, Hirtl A, Dobrozemsky G, Bergmann H, Kletter K, Dudczak R, et al.
Z Med Phys
. 2011 Jan;
22(1):29-39.
PMID: 21251804
Purpose: To assess the influence of reconstruction algorithms for positron emission tomography (PET) based volume quantification. The specifically detected activity in the threshold defined volume was investigated for different reconstruction...
10.
Nics L, Haeusler D, Wadsak W, Wagner K, Dudczak R, Kletter K, et al.
Nucl Med Biol
. 2011 Jan;
38(1):13-7.
PMID: 21220125
Introduction: Carboxylesterases (CES) play a very important role in the hydrophilic biotransformation of a huge number of structurally diverse drugs and especially play a leading part in the catabolic pathway...